CA1094094A - Asymmetric catalysis - Google Patents
Asymmetric catalysisInfo
- Publication number
- CA1094094A CA1094094A CA259,753A CA259753A CA1094094A CA 1094094 A CA1094094 A CA 1094094A CA 259753 A CA259753 A CA 259753A CA 1094094 A CA1094094 A CA 1094094A
- Authority
- CA
- Canada
- Prior art keywords
- carbon atoms
- alkyl
- bis
- aryl
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
- B01J31/2414—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom comprising aliphatic or saturated rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/821—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/827—Iridium
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
Catalytic asymmetric hydrogenation of the Z geometric isomer of a compound of the formula wherein R and R1 each independently represent substituents as desired in the hydrogenation product or its derivatives, R2 represents -CN, , or -?-O-R6 wherein R4 and R5 each indepen-ently represent hydrogen, alkyl having from 1 to 5 carbon atoms or aryl, R6 represents hydrogen, alkyl having from 1 to 5 carbon atoms, aryl or an alkali metal, and R3 represents -?-O-R7 or -?-R8 wherein R7 and R8 each independently represent alkyl having from 1 to 5 carbon atoms or aryl; provided that, when R3 is -?-R8, R2 cannot be -?-O-R6 or
Catalytic asymmetric hydrogenation of the Z geometric isomer of a compound of the formula wherein R and R1 each independently represent substituents as desired in the hydrogenation product or its derivatives, R2 represents -CN, , or -?-O-R6 wherein R4 and R5 each indepen-ently represent hydrogen, alkyl having from 1 to 5 carbon atoms or aryl, R6 represents hydrogen, alkyl having from 1 to 5 carbon atoms, aryl or an alkali metal, and R3 represents -?-O-R7 or -?-R8 wherein R7 and R8 each independently represent alkyl having from 1 to 5 carbon atoms or aryl; provided that, when R3 is -?-R8, R2 cannot be -?-O-R6 or
Description
"
ASYMMETRIC CATALYSIS
This invention relates to new catalytic asymmetric hydrogenation processes. More specifically, this invention is directed to a hydrogenation process which provides outstanding levels of optical purity.
Homogeneous catalysis, i.e., those catalyzed reactions that are conducted where both reactants and catalysts are soluble in the reaction mass, have been found to be particularly useful in processes wherein an asymmetric result is obtained. For in-stance, it has been found that when an olefin, which is capableof forming a racemic mixture is hydrogenated in the presence of a homogeneous, optically active catalyst, one or the other of the possible optical enantiomorphs is obtained in a ma;or amount with the other optical enantiomorph being obtained in minor amounts.
Furthermore, it has been found that certain such olefinic sub-strates, for instance, precursors of c~~-amino acids containing ~-acylamido and carboxylic acids, salts, esters or amides substituents, are particularly amenable to hydrogenation with homogeneous, optically active catalysts. Such catalytic asymmet-ric hydrogenation processes have resulted in the production oflarge amounts of the desired optical enantiomorph. It has more recently been found that certain homogeneous, optically active catalysts containing optically active bis phosphine ligands pro-vide outstanding levels of optical purity, i.e., reaching 80%
and higher with such cC-amino acid precursors. Other olefinic substrates which would provide such outstanding levels of optical purity of optical enantiomorphs leading to o~`-amino acids, upon hydrogenation, are particularly desirable.
It is an object of the present invention to provide such olefinic substrates.
It is a further ob~ect to provide novel catalytic asymmetric hydrogenation processes which produce large amounts of the desired optical enantiomorph. ~
` 43-4257A
These and other objects, aspects and advantages of this invention will become apparent from a consideration of the accompanying specification and claims.
Summary of the Invention In accordance with the above ob~ects, the present inven-tion provides catalytic asymmetric hydrogenation of the Z geomet-ric isomer of a compound o~ the formula Rl ,R2 R~ C = C~NH R3 wherein R and Rl each independently represent substituents as desired in the hydrogenation product or its derivatives, R2 represents -CN,-C-N~ 5 or -C-0-R6 wherein R4 and R5 each indepen-dently represent hydrogen, alkyl having from 1 to 5 carbon atomsor aryl, R6 represents hydrogen, alkyl having from 1 to 5 carbon atoms, aryl or an alkali metal and R3 represents -C-o-R7 or -C-R8 wherein R7 and R8 each independently represent alkyl having from 1 to 5 carbon atoms or aryl; provided that, when R3 is 0 0 o R4 -C-R8, R2 cannot be -C-0-R6 or -C-N~ 5 , in the presence of a homogeneous, coordination complex catalyst comprising rhodium, iridium or ruthenium in combination with an optically active bis phosphine ligand. This process provides outstanding levels of optical purity of desired optical enantiomorphs.
Description of the Preferred Embodiments The hydrogenation reaction is illustrated by the following equation:
~ C = C ~ +H2 > ~ CH-CH
R ~NH-R3 optically R NH-R3 active catalyst shows one or both carbon atoms are asymmetric .
wherein R, Rl, R2 and R3 have the same meaning as described above.
It has been found that the geometric stereochemistry of the olefinic substrate being hydrogenated effects the results ob-tained. In general, it is necessary to utilize the Z geometric isomer to realize the outstanding levels of optical purity with the olefinic substrates of this inventlon. The E and Z geometric isomer nomenclature is described in detail in The Journal of Organic Chemistry, Vol. 35, No. 9, September 1970, pp 2849-2867.
It has been found that either the E or Z geometric isomer will, upon hydrogenation, produce the same optical enantiomorph when using the same catalyst but at different levels of optical purity.
R, Rl, R4, R5, R6, R7, and R8 can be exemplified by alkyl groups such as methyl, ethyl, propyl, etc. and by aryl groups such as phenyl. Those skilled in the art will recognize that the sub-stituents on the olefinic substrate can be selected from a large number of groups and that this is limited only by the optical enantiomorph that is the desired end-product. Furthermore, it may occur that such substituent groups are themselves precursors of substituents that are desired substituents. For instance, if the desired substituent is hydroxyl the unsaturated precursor o might contain the substituents -O-C-CH3 or -0-CH3 which would pro-vide the hydroxyl by simple hydrolysis after the catalytic asym-metric hydrogenation.
The optical enantiomorphs resulting from the process of this invention are particularly desirable in that optical activity is a desirable characteristic of C~-amino acids, i.e. normally only one or the other optical enantiomorphs is useful in living organ-isms. For instance, those optical enantiomorphs of c~-amino acids resulting from this process which have phenyl or substituted phenyl substituents on the ~ position lead to desirable L-phenylalanines.
The compounds represented by the following structural formula provide excellent results with the process of this invention and therefore represent compounds particularly amenable to the hydrogenation process of this invention ~ C = C~ 3 R ~ NH-R
wherein R, Rl and R3 have the same meaning as described above.
Particularly preferred embodiments of this invention are the catalytic asymmetric hydrogenation of (Z)-ethyl-2-(N-ethoxycarbonylamino)-3-phenyl-2-propenoate and (Z)-2-benzamido-3-- phenyl-2-propenenitr~le.
The L enantiomorph of phenylalanine can be readily derived from such procedures.
Such hydrogenation reactions are usually conducted in a solvent, such as benzene, ethanol, 2-propanol, toluene, cyclo-hexane, and mixtures of these solvents. Almost any aromatic or saturated alkane or cycloalkane solvent, which is inactive to the hydrogenation condltions of this reaction, can be used. The preferred solvents are alcohols particularly methanol, ethanol and 2-propanol.
The homogeneous, optically active catalysts useful in this invention are soluble coordination complexes comprising a metal which is rhodium, iridium or ruthenium in combination with at least one optically active bis phosphine ligand, preferably at least about 0.5 moles of bis phosphine ligand per mole of metal. These catalysts are soluble in the reaction mass and are therefore referred to as "homogeneous" catalysts.
These catalysts contain optically active bis phosphine compounds of general formulae I and II below. These bis phos-phine compounds are characterized by the structural formula A ~ P ~ CH2CH2 ~ P - A
B B
wherein A and B each independently represent substituted and un-substituted alkyl of from 1 to 12 carbon atoms, substituted and _c~ _ unsubstltuted cycloalkyl having from 4 to 7 carbon atoms, substi-tutued and unsubstituted aryl; provided that such substituents provide no significant interference with the steric requirements around the phosphorus atom and A and B are different.
Among such bis phosphine compounds, those having two dissimilar aryl groups on each phosphorus atom are also preferred, particularly those wherein one such aryl group has an alkoxy sub-stituent at the ortho position.
More preferred bis phosphine compounds useful in the present invention are the optically active bis phosphines charac-terized by the structural formula , 2C 2 P X II
Y Y
wherein X represents substituted and unsubstituted phenyl, Y represents substituted and unsubstituted 2-alkoxyphenyl wherein the alkoxy has from 1 to 6 carbon atoms; pro-vided that such substituents provide no significant interference with the steric requirements around the phosphorus atom and X and Y are different.
The catalysts prepared utilizing those optically active bis phosphine compounds of more specific formula III, below, are more particularly preferred in the catalytic asymmetric hydrogena-tion reactions of this invention.
Still more particularly preferred optically active bis phosphine compounds useful in the present invention are charac-terized by the structural formula M ~ P ~ CH2CH2 ~ P - M III
N N
~ R' wherein M represents R"'0 N represents ~
43_4257A ~094094 R' and R" each independently represent hydrogen, halogen, alkyl having from 1 to 6 carbon atoms and alkoxy having from 1 to 6 carbon atoms, and R"' represents normal alkyl having from 1 to 6 carbon atoms;
provided that M and N are different.
A particularly preferred optically active bis phosphine compound useful in the present invention is 1,2-bis(o-anisyl-phenylphosphino) ethane.
Other exemplary optically active bis phosphine compounds useful in this invention are:
1,2-bis(o-anisyl-4-methylphenylphosphino) ethane 1,2-bis(o-anisyl-4-chlorophenylphosphino) ethane 1,2-bis(o-anisyl-3-chlorophenylphosphino) ethane 1,2-bis(o-anisyl-4-bromophenylphosphino) ethane 1,2-bis[(2-methoxy-5-chlorophenyl)-phenylphosphino] ethane 1,2-bis[(2-methoxy-5-bromophenyl)-phenylphosphino] ethane 1,2-bis(2-ethoxyphenylphenylphosphino) ethane 1,2-bis[o-anisyl-~-phenylphenyl)phosphino] ethane 1,2-bis[(2-methoxy-4-methylphenyl)-phenylphosphino] ethane 1,2-bis(2-ethoxyphenyl-4-chlorophenylphosphino) ethane i,2-bis(o-anisyl-2-methylphenylphosphino) ethane 1,2-bis(o-anisyl-4-ethylphenylphosphino) ethane 1,2-bis(o-anisyl-3-ethylphenylphosphino) ethane 1,2-bis(o-anisyl-3-phenylphenylphosphino) ethane For these bis phosphine compounds to be useful in asymmetric hydrogenation reactions they must be utilized as the optically active enantiomorph and not in the meso form.
Optical activity of the coordinated complex catalysts useful in this invention resides in the bis phosphine ligand.
This optical activity results from having two different groups, in addition to the ethane bridge, on the phosphorus atom.
Illustrative coordination metal complexes can be repre-sented by the formula MeTL wherein Me is a transition metal selec-ted from the group consisting of rhodium, iridium and ruthenium;
T is selected from the group consisting of hydrogen, fluorine, bromine, chlorine and iodine; L is the optically active bis phos-phine ligand as previously defined.
It has been found that outstanding levels of optical purity of the desired optical enantiomorphs can be achieved not only with the above-described catalysts represented by the formula MeTL, which are coordination complexes of a metal selected from the group consisting of rhodium, lridium and ruthenium, but can also be achieved when the hydrogenation is carried out in the presence of an in situ complex catalyst that comprises a solution of a transition metal selected from the group consisting of rhodium, iridium and ruthenium and at least about 0.5 moles of the optically active bis phosphine ligand per mole of metal. For instance, such catalysts can be prepared by dissolving a soluble compound of the appropriate metal in a suitable solvent together with an optically active bis phosphine compound as the ligand wherein the ratio of ligand to metal is at least 0.5 moles of ligand per mole of metal, preferably one mole of ligand per mole of metal. It has been found that the catalyst is formed in situ by addlng a soluble metal compound to the reaction mass together with the addition of the proper amount of the optically active bis phosphine li~and to the reaction mass either before or during hydrogenation.
The preferred metal for use in this process is rhodium.
Soluble rhodium compounds that can be utilized include rhodium trichloride hydrate, rhodium tribromide hydrate, rhodium sulfate, organic rhodium complexes with ethylene, propylene, etc., and bis olefins such as 1,5-cyclooctadiene and 1,5-hexadiene, bicyclo-
ASYMMETRIC CATALYSIS
This invention relates to new catalytic asymmetric hydrogenation processes. More specifically, this invention is directed to a hydrogenation process which provides outstanding levels of optical purity.
Homogeneous catalysis, i.e., those catalyzed reactions that are conducted where both reactants and catalysts are soluble in the reaction mass, have been found to be particularly useful in processes wherein an asymmetric result is obtained. For in-stance, it has been found that when an olefin, which is capableof forming a racemic mixture is hydrogenated in the presence of a homogeneous, optically active catalyst, one or the other of the possible optical enantiomorphs is obtained in a ma;or amount with the other optical enantiomorph being obtained in minor amounts.
Furthermore, it has been found that certain such olefinic sub-strates, for instance, precursors of c~~-amino acids containing ~-acylamido and carboxylic acids, salts, esters or amides substituents, are particularly amenable to hydrogenation with homogeneous, optically active catalysts. Such catalytic asymmet-ric hydrogenation processes have resulted in the production oflarge amounts of the desired optical enantiomorph. It has more recently been found that certain homogeneous, optically active catalysts containing optically active bis phosphine ligands pro-vide outstanding levels of optical purity, i.e., reaching 80%
and higher with such cC-amino acid precursors. Other olefinic substrates which would provide such outstanding levels of optical purity of optical enantiomorphs leading to o~`-amino acids, upon hydrogenation, are particularly desirable.
It is an object of the present invention to provide such olefinic substrates.
It is a further ob~ect to provide novel catalytic asymmetric hydrogenation processes which produce large amounts of the desired optical enantiomorph. ~
` 43-4257A
These and other objects, aspects and advantages of this invention will become apparent from a consideration of the accompanying specification and claims.
Summary of the Invention In accordance with the above ob~ects, the present inven-tion provides catalytic asymmetric hydrogenation of the Z geomet-ric isomer of a compound o~ the formula Rl ,R2 R~ C = C~NH R3 wherein R and Rl each independently represent substituents as desired in the hydrogenation product or its derivatives, R2 represents -CN,-C-N~ 5 or -C-0-R6 wherein R4 and R5 each indepen-dently represent hydrogen, alkyl having from 1 to 5 carbon atomsor aryl, R6 represents hydrogen, alkyl having from 1 to 5 carbon atoms, aryl or an alkali metal and R3 represents -C-o-R7 or -C-R8 wherein R7 and R8 each independently represent alkyl having from 1 to 5 carbon atoms or aryl; provided that, when R3 is 0 0 o R4 -C-R8, R2 cannot be -C-0-R6 or -C-N~ 5 , in the presence of a homogeneous, coordination complex catalyst comprising rhodium, iridium or ruthenium in combination with an optically active bis phosphine ligand. This process provides outstanding levels of optical purity of desired optical enantiomorphs.
Description of the Preferred Embodiments The hydrogenation reaction is illustrated by the following equation:
~ C = C ~ +H2 > ~ CH-CH
R ~NH-R3 optically R NH-R3 active catalyst shows one or both carbon atoms are asymmetric .
wherein R, Rl, R2 and R3 have the same meaning as described above.
It has been found that the geometric stereochemistry of the olefinic substrate being hydrogenated effects the results ob-tained. In general, it is necessary to utilize the Z geometric isomer to realize the outstanding levels of optical purity with the olefinic substrates of this inventlon. The E and Z geometric isomer nomenclature is described in detail in The Journal of Organic Chemistry, Vol. 35, No. 9, September 1970, pp 2849-2867.
It has been found that either the E or Z geometric isomer will, upon hydrogenation, produce the same optical enantiomorph when using the same catalyst but at different levels of optical purity.
R, Rl, R4, R5, R6, R7, and R8 can be exemplified by alkyl groups such as methyl, ethyl, propyl, etc. and by aryl groups such as phenyl. Those skilled in the art will recognize that the sub-stituents on the olefinic substrate can be selected from a large number of groups and that this is limited only by the optical enantiomorph that is the desired end-product. Furthermore, it may occur that such substituent groups are themselves precursors of substituents that are desired substituents. For instance, if the desired substituent is hydroxyl the unsaturated precursor o might contain the substituents -O-C-CH3 or -0-CH3 which would pro-vide the hydroxyl by simple hydrolysis after the catalytic asym-metric hydrogenation.
The optical enantiomorphs resulting from the process of this invention are particularly desirable in that optical activity is a desirable characteristic of C~-amino acids, i.e. normally only one or the other optical enantiomorphs is useful in living organ-isms. For instance, those optical enantiomorphs of c~-amino acids resulting from this process which have phenyl or substituted phenyl substituents on the ~ position lead to desirable L-phenylalanines.
The compounds represented by the following structural formula provide excellent results with the process of this invention and therefore represent compounds particularly amenable to the hydrogenation process of this invention ~ C = C~ 3 R ~ NH-R
wherein R, Rl and R3 have the same meaning as described above.
Particularly preferred embodiments of this invention are the catalytic asymmetric hydrogenation of (Z)-ethyl-2-(N-ethoxycarbonylamino)-3-phenyl-2-propenoate and (Z)-2-benzamido-3-- phenyl-2-propenenitr~le.
The L enantiomorph of phenylalanine can be readily derived from such procedures.
Such hydrogenation reactions are usually conducted in a solvent, such as benzene, ethanol, 2-propanol, toluene, cyclo-hexane, and mixtures of these solvents. Almost any aromatic or saturated alkane or cycloalkane solvent, which is inactive to the hydrogenation condltions of this reaction, can be used. The preferred solvents are alcohols particularly methanol, ethanol and 2-propanol.
The homogeneous, optically active catalysts useful in this invention are soluble coordination complexes comprising a metal which is rhodium, iridium or ruthenium in combination with at least one optically active bis phosphine ligand, preferably at least about 0.5 moles of bis phosphine ligand per mole of metal. These catalysts are soluble in the reaction mass and are therefore referred to as "homogeneous" catalysts.
These catalysts contain optically active bis phosphine compounds of general formulae I and II below. These bis phos-phine compounds are characterized by the structural formula A ~ P ~ CH2CH2 ~ P - A
B B
wherein A and B each independently represent substituted and un-substituted alkyl of from 1 to 12 carbon atoms, substituted and _c~ _ unsubstltuted cycloalkyl having from 4 to 7 carbon atoms, substi-tutued and unsubstituted aryl; provided that such substituents provide no significant interference with the steric requirements around the phosphorus atom and A and B are different.
Among such bis phosphine compounds, those having two dissimilar aryl groups on each phosphorus atom are also preferred, particularly those wherein one such aryl group has an alkoxy sub-stituent at the ortho position.
More preferred bis phosphine compounds useful in the present invention are the optically active bis phosphines charac-terized by the structural formula , 2C 2 P X II
Y Y
wherein X represents substituted and unsubstituted phenyl, Y represents substituted and unsubstituted 2-alkoxyphenyl wherein the alkoxy has from 1 to 6 carbon atoms; pro-vided that such substituents provide no significant interference with the steric requirements around the phosphorus atom and X and Y are different.
The catalysts prepared utilizing those optically active bis phosphine compounds of more specific formula III, below, are more particularly preferred in the catalytic asymmetric hydrogena-tion reactions of this invention.
Still more particularly preferred optically active bis phosphine compounds useful in the present invention are charac-terized by the structural formula M ~ P ~ CH2CH2 ~ P - M III
N N
~ R' wherein M represents R"'0 N represents ~
43_4257A ~094094 R' and R" each independently represent hydrogen, halogen, alkyl having from 1 to 6 carbon atoms and alkoxy having from 1 to 6 carbon atoms, and R"' represents normal alkyl having from 1 to 6 carbon atoms;
provided that M and N are different.
A particularly preferred optically active bis phosphine compound useful in the present invention is 1,2-bis(o-anisyl-phenylphosphino) ethane.
Other exemplary optically active bis phosphine compounds useful in this invention are:
1,2-bis(o-anisyl-4-methylphenylphosphino) ethane 1,2-bis(o-anisyl-4-chlorophenylphosphino) ethane 1,2-bis(o-anisyl-3-chlorophenylphosphino) ethane 1,2-bis(o-anisyl-4-bromophenylphosphino) ethane 1,2-bis[(2-methoxy-5-chlorophenyl)-phenylphosphino] ethane 1,2-bis[(2-methoxy-5-bromophenyl)-phenylphosphino] ethane 1,2-bis(2-ethoxyphenylphenylphosphino) ethane 1,2-bis[o-anisyl-~-phenylphenyl)phosphino] ethane 1,2-bis[(2-methoxy-4-methylphenyl)-phenylphosphino] ethane 1,2-bis(2-ethoxyphenyl-4-chlorophenylphosphino) ethane i,2-bis(o-anisyl-2-methylphenylphosphino) ethane 1,2-bis(o-anisyl-4-ethylphenylphosphino) ethane 1,2-bis(o-anisyl-3-ethylphenylphosphino) ethane 1,2-bis(o-anisyl-3-phenylphenylphosphino) ethane For these bis phosphine compounds to be useful in asymmetric hydrogenation reactions they must be utilized as the optically active enantiomorph and not in the meso form.
Optical activity of the coordinated complex catalysts useful in this invention resides in the bis phosphine ligand.
This optical activity results from having two different groups, in addition to the ethane bridge, on the phosphorus atom.
Illustrative coordination metal complexes can be repre-sented by the formula MeTL wherein Me is a transition metal selec-ted from the group consisting of rhodium, iridium and ruthenium;
T is selected from the group consisting of hydrogen, fluorine, bromine, chlorine and iodine; L is the optically active bis phos-phine ligand as previously defined.
It has been found that outstanding levels of optical purity of the desired optical enantiomorphs can be achieved not only with the above-described catalysts represented by the formula MeTL, which are coordination complexes of a metal selected from the group consisting of rhodium, lridium and ruthenium, but can also be achieved when the hydrogenation is carried out in the presence of an in situ complex catalyst that comprises a solution of a transition metal selected from the group consisting of rhodium, iridium and ruthenium and at least about 0.5 moles of the optically active bis phosphine ligand per mole of metal. For instance, such catalysts can be prepared by dissolving a soluble compound of the appropriate metal in a suitable solvent together with an optically active bis phosphine compound as the ligand wherein the ratio of ligand to metal is at least 0.5 moles of ligand per mole of metal, preferably one mole of ligand per mole of metal. It has been found that the catalyst is formed in situ by addlng a soluble metal compound to the reaction mass together with the addition of the proper amount of the optically active bis phosphine li~and to the reaction mass either before or during hydrogenation.
The preferred metal for use in this process is rhodium.
Soluble rhodium compounds that can be utilized include rhodium trichloride hydrate, rhodium tribromide hydrate, rhodium sulfate, organic rhodium complexes with ethylene, propylene, etc., and bis olefins such as 1,5-cyclooctadiene and 1,5-hexadiene, bicyclo-
2.2.1-hepta-2,5-diene and other dienes which can form bidentate ~094094 ligands, or an active form of metallic rhodium that is readily solubllized.
It has been found that a preferred embodiment of this invention is the hydrogenation process where the optically active bis phosphine ligand is present in a ratio of about 0.5 to about 2.0, preferably, 1.0, moles of bis phosphine ligand per mole of metal. In practice, it is preferred to have the optically active catalyst in a solid form for purposes of handling and storage.
It has been found that outstanding results can be obtained with solid, cationic coordination metal complexes.
Cationic coordination metal complexes containing one mole of the optically active bis phosphine ligand per mole of metal and a chelating bis olefin represent a preferred form of the catalysts useful in the present invention. For instance, using organic rhodium complexes, as described above, one can prepare such cationic coordination rhodium complexes by slurrying the organic rhodlum complex in an alcohol, such as ethanol, adding one mole per mole of rhodium of the optically active bis phosphine compound so that an ionic solution is formed, followed by the addition of a suitable anion, such as, for instance, tetrafluoroborate, tetraphenylborate or any other anion that will result in the precipitation or crystallization of a solid, cationic coordination metal complex either directly from the solvent or upon treatment in an appropriate solvent.
Exemplary cationic coordination metal complexes are cyclooctadiene-1,5-~1,2-bis(o-anisylphenylphosphino) ethane]
rhodium tetrafluoroborate, cyclooctadiene-1,5-[1,2-bis(o-anisyl-phenylphosphino) ethane] rhodium tetraphenylborate and bicyclo-2.2.1-hepta-2,5-diene-[1,2-bis(_-anisylphenylphosphino) ethane]
rhodium tetrafluoroborate.
Without pre~udice to the present invention it is thought that the catalyst is present actually as a catalyst precursor and that upon contact with hydrogen the catalyst is converted to an ~05~4094 active form. This conversion can, of course, be carried out during the actual hydrogenation or can be accomplished by sub-jecting the catalyst (or precursor) to hydrogen prior to addition to the reaction mass to be hydrogenated.
As previously noted, the catalyst can be added to the solvent either as a compound per se or as its components which then form the catalyst in situ. When the catalyst is added as its components it may be added prior to or after the addition of the olefinic substrate. Components for the preparation of the catalyst in situ are the soluble metal compound and the optically active bis phosphine compound. The catalyst can be added in any effective catalytic amount and generally in the range of about 0.001% to about 5% by weight of contained metal based on the olefinic substrate to be hydrogenated.
Within the practical limits, means should be provided so as to avoid contacting the catalyst or reaction mass with oxidizing materials. In particular, care should be taken so as to avoid contact with oxygen. It is preferred to carry out the hydrogenation reaction preparation and actual reaction in gases (other than H2) that are inert to both reactants and catalysts such as, for instance, nitrogen or argon.
After addition of the reactants and catalyst to the solvent, hydrogen is added to the mixture until about 0.5 to about 5 times the mole quantity of the olefinic substrate present has been added. The pressure of the system will necessarily vary since it will be dependent upon the type of reactant, type of catalyst, size of hydrogenation apparatus, amount of reactants and catalyst and amount of solvent. Lower pressures, including atmospheric and sub-atmospheric pressure can be used as well as higher pressure.
Reaction temperatures may be in the range of about -20C. to about 110C. Higher temperatures may be used but are normally not required and may lead to an increase of side reac-tions.
Upon completion of the reaction which, is determined by conventional means, the product is recovered by conventional means.
Many naturally occurring products and medicaments exist in an optically active form. In these cases only the L or D form is usually effective. Synthetic preparation of these compounds in the past has requlred an additional step of separating the products into its enantlomorphs. This process is expensive and time con-suming. The process of the present invention permits the directformation of desired optical enantiomorphs with outstanding opti-cal purity thus eliminating much of the time consuming and expen-sive separation of such optical enantiomorphs. Furthermore, the process provides a hlgher yield of the desired optical enantio-morph while concurrently decreasing the yleld of the unwanted optical enantiomorph.
The hydrogenation process of this invention is particu-larly desirable because of its ability to not only provide an unusually high optical purity of the desired optical enantiomorph but also because of its ability to afford a rapid rate of hydro-genation at low catalyst concentrations.
The following examples will serve to illustrate certain specific embodiments within the scope of this invention and are not to be construed as limiting the scope thereof. In the exam-ples, the percent optical purity is determined by the following equation (it being understood that the optical activity, ex-pressed as specific rotation, is measured in the same solvent):
%Opt cal = Observed optical activity of the mixture x 100 Purity Optical activity of pure optical isomer.
43-4257A 10~4094 Example 1 Preparation of (Z)-ethyl-2-(N-ethoxycarbon~lamino)-3-phenyl-2-propenoate To a solution of 21.0 g. (0.12 mole) of ethyl N-(ethoxycarbonyl) glycine, 10.08 g. (0.096 mole) of benzaldehyde and 200 ml. of ethyl ether, maintained at 5C., was added 3.0 g.
(0.13 mole) of sodium metal. The mixture was stirred 18 hours at ambient temperature and was filtered to remove the solid pre-cipitate. The ethereal filtrate was washed with water and dried.
The ether was stripped and the solid residue was recrystallized from toluene. The yield was 4.9 g., m.p. 102-107. The product was identified as (Z)-ethyl-2-(N-ethoxycarbonylamino)-3-phenyl-2-propenoate by NMR, GLC, and W analysis.
Example 2 Preparation of ethyl-2-(N-ethoxycarbonylamino)-3-phenylpropanoate A solution of 2.29 g. of (Z)-ethyl-2-(N-ethoxycarbonyl-amino)-3-phenyl-2-propenoate, 0.0105 g. of cyclooctadiene-1,5-[1,2-bis(o-anisylphenylphosphino) ethane] rhodium tetrafluoro-borate and 30 cc. of ethanol was hydrogenated at 3 atm. and 50C.
After 2 1/2 hours, the solution was stripped on a rotary evapora-tor. NMR analysis indicated that hydrogenation was complete.
The hydrogenation product, ethyl-2-(N-ethoxycarbonyl-amino)-3-phenylpropanoate, was hydrolyzed to phenylalanine (with the L enantiomorph in ma~or amount) in the following manner: To a solution of the res~due from the above stripping in 30 cc. of acetic acid at 75C., hydrogen bromide gas was slowly bubbled in the resulting solution for 1 hour. After holding for several hours, the acetic acid was removed on a rotary evaporator. The resulting residue was added to 25 cc. of water containing 2 cc.
of 48% aqueous hydrogen bromide. The mixture was heated at re-flux for 3 1/2 hours, cooled to 25C. and extracted with chloro-form to remove non-hydrolyzed organics The water solution, containing the phenylalanine hydrobromide salt and 1 cc. of added acetic acid was neutralized to pH 3 with a 50% NaOH solution. The optical rotation of the neutralized solution (100 cc.), containing the phenylalanine was determined with a polarimeter. [OC]DO =
-27.95 (C=l in water), optical purity equals 88.7%.
Example 3 Preparation of N-benzamidoacetonitrile Sodium carbonate (0.108 mole) was added to a solution containing 20 g. of aminoacetonitrile hydrochloride (0.216 mole) in 150 cc. of water. The solution was cooled to 5C. and 18.1 g.
(0.216 mole) of sodium bicarbonate was added. 30.4 g. of benzoyl chloride (0.216 mole) was added dropwise over about 1 1/2 hours to the cold aqueous solution and a solid formed. The resulting mass was allowed to warm to 20C.; the solid was collected and washed thoroughly with water. The dry weight of the recovered material, which was crude N-benzamidoacetonitrile, was 33 g.
(96% yield) m.p. 137-139C. This material was recrystallized from 100 cc. of methanol and 29 g. was recovered.
Example 4 Preparation of (Z)-2-benzamido-3-phenyl-2-propenenitrile Hydrogen chloride gas was bubbled into a solution con-taining 4 g. of benzaldehyde (0.037 mole) and 6 g. of N-benzamido-acetonitrile (0.037 mole) in 100 cc. of diethyl ether maintained at 0-5C. Upon holding for about 1 1/2 hours a solid precipitates;
10.4 g. of this solid was collected by filtration.
The 10.4 g. of the solid collected above was added to a solution of 4 g. of sodium carbonate in 100 cc. of cold (0-5C.) water. The mixture was stirred for 1 hour at 5C., then 10 cc.
of acetone was added and the resulting mass allowed ~o warm to 20C. The product, which was crude (Z)-2-benzamido-3-phenyl-2-propenenitrile (NMR), was eollected and washed with water. The dry weight of collected material was 8.5 g. (92% yield). The 8.5 g. of this material was crystalllzed from 85 cc. of ethanol.
Recovery was 6.8 g., m.p. 164-165.
Example 5 Preparation of 2-benzamido-3-phenylpropanenitrile (A) A solution of 0.9956 g. of (Z)-2-benzamido-3-phenyl-2-propenenitrile, .oo46 g. of cyclooctadiene-1,5-[1,2-bis (o-anisylphenylphosphino) ethane] rhodium tetrafluoroborate and 0.5 cc. of acetic acid in 30 cc. of methanol was hydrogenated in a Hoke bomb at 27 atm. and 50C. Hydrogenation was complete in
It has been found that a preferred embodiment of this invention is the hydrogenation process where the optically active bis phosphine ligand is present in a ratio of about 0.5 to about 2.0, preferably, 1.0, moles of bis phosphine ligand per mole of metal. In practice, it is preferred to have the optically active catalyst in a solid form for purposes of handling and storage.
It has been found that outstanding results can be obtained with solid, cationic coordination metal complexes.
Cationic coordination metal complexes containing one mole of the optically active bis phosphine ligand per mole of metal and a chelating bis olefin represent a preferred form of the catalysts useful in the present invention. For instance, using organic rhodium complexes, as described above, one can prepare such cationic coordination rhodium complexes by slurrying the organic rhodlum complex in an alcohol, such as ethanol, adding one mole per mole of rhodium of the optically active bis phosphine compound so that an ionic solution is formed, followed by the addition of a suitable anion, such as, for instance, tetrafluoroborate, tetraphenylborate or any other anion that will result in the precipitation or crystallization of a solid, cationic coordination metal complex either directly from the solvent or upon treatment in an appropriate solvent.
Exemplary cationic coordination metal complexes are cyclooctadiene-1,5-~1,2-bis(o-anisylphenylphosphino) ethane]
rhodium tetrafluoroborate, cyclooctadiene-1,5-[1,2-bis(o-anisyl-phenylphosphino) ethane] rhodium tetraphenylborate and bicyclo-2.2.1-hepta-2,5-diene-[1,2-bis(_-anisylphenylphosphino) ethane]
rhodium tetrafluoroborate.
Without pre~udice to the present invention it is thought that the catalyst is present actually as a catalyst precursor and that upon contact with hydrogen the catalyst is converted to an ~05~4094 active form. This conversion can, of course, be carried out during the actual hydrogenation or can be accomplished by sub-jecting the catalyst (or precursor) to hydrogen prior to addition to the reaction mass to be hydrogenated.
As previously noted, the catalyst can be added to the solvent either as a compound per se or as its components which then form the catalyst in situ. When the catalyst is added as its components it may be added prior to or after the addition of the olefinic substrate. Components for the preparation of the catalyst in situ are the soluble metal compound and the optically active bis phosphine compound. The catalyst can be added in any effective catalytic amount and generally in the range of about 0.001% to about 5% by weight of contained metal based on the olefinic substrate to be hydrogenated.
Within the practical limits, means should be provided so as to avoid contacting the catalyst or reaction mass with oxidizing materials. In particular, care should be taken so as to avoid contact with oxygen. It is preferred to carry out the hydrogenation reaction preparation and actual reaction in gases (other than H2) that are inert to both reactants and catalysts such as, for instance, nitrogen or argon.
After addition of the reactants and catalyst to the solvent, hydrogen is added to the mixture until about 0.5 to about 5 times the mole quantity of the olefinic substrate present has been added. The pressure of the system will necessarily vary since it will be dependent upon the type of reactant, type of catalyst, size of hydrogenation apparatus, amount of reactants and catalyst and amount of solvent. Lower pressures, including atmospheric and sub-atmospheric pressure can be used as well as higher pressure.
Reaction temperatures may be in the range of about -20C. to about 110C. Higher temperatures may be used but are normally not required and may lead to an increase of side reac-tions.
Upon completion of the reaction which, is determined by conventional means, the product is recovered by conventional means.
Many naturally occurring products and medicaments exist in an optically active form. In these cases only the L or D form is usually effective. Synthetic preparation of these compounds in the past has requlred an additional step of separating the products into its enantlomorphs. This process is expensive and time con-suming. The process of the present invention permits the directformation of desired optical enantiomorphs with outstanding opti-cal purity thus eliminating much of the time consuming and expen-sive separation of such optical enantiomorphs. Furthermore, the process provides a hlgher yield of the desired optical enantio-morph while concurrently decreasing the yleld of the unwanted optical enantiomorph.
The hydrogenation process of this invention is particu-larly desirable because of its ability to not only provide an unusually high optical purity of the desired optical enantiomorph but also because of its ability to afford a rapid rate of hydro-genation at low catalyst concentrations.
The following examples will serve to illustrate certain specific embodiments within the scope of this invention and are not to be construed as limiting the scope thereof. In the exam-ples, the percent optical purity is determined by the following equation (it being understood that the optical activity, ex-pressed as specific rotation, is measured in the same solvent):
%Opt cal = Observed optical activity of the mixture x 100 Purity Optical activity of pure optical isomer.
43-4257A 10~4094 Example 1 Preparation of (Z)-ethyl-2-(N-ethoxycarbon~lamino)-3-phenyl-2-propenoate To a solution of 21.0 g. (0.12 mole) of ethyl N-(ethoxycarbonyl) glycine, 10.08 g. (0.096 mole) of benzaldehyde and 200 ml. of ethyl ether, maintained at 5C., was added 3.0 g.
(0.13 mole) of sodium metal. The mixture was stirred 18 hours at ambient temperature and was filtered to remove the solid pre-cipitate. The ethereal filtrate was washed with water and dried.
The ether was stripped and the solid residue was recrystallized from toluene. The yield was 4.9 g., m.p. 102-107. The product was identified as (Z)-ethyl-2-(N-ethoxycarbonylamino)-3-phenyl-2-propenoate by NMR, GLC, and W analysis.
Example 2 Preparation of ethyl-2-(N-ethoxycarbonylamino)-3-phenylpropanoate A solution of 2.29 g. of (Z)-ethyl-2-(N-ethoxycarbonyl-amino)-3-phenyl-2-propenoate, 0.0105 g. of cyclooctadiene-1,5-[1,2-bis(o-anisylphenylphosphino) ethane] rhodium tetrafluoro-borate and 30 cc. of ethanol was hydrogenated at 3 atm. and 50C.
After 2 1/2 hours, the solution was stripped on a rotary evapora-tor. NMR analysis indicated that hydrogenation was complete.
The hydrogenation product, ethyl-2-(N-ethoxycarbonyl-amino)-3-phenylpropanoate, was hydrolyzed to phenylalanine (with the L enantiomorph in ma~or amount) in the following manner: To a solution of the res~due from the above stripping in 30 cc. of acetic acid at 75C., hydrogen bromide gas was slowly bubbled in the resulting solution for 1 hour. After holding for several hours, the acetic acid was removed on a rotary evaporator. The resulting residue was added to 25 cc. of water containing 2 cc.
of 48% aqueous hydrogen bromide. The mixture was heated at re-flux for 3 1/2 hours, cooled to 25C. and extracted with chloro-form to remove non-hydrolyzed organics The water solution, containing the phenylalanine hydrobromide salt and 1 cc. of added acetic acid was neutralized to pH 3 with a 50% NaOH solution. The optical rotation of the neutralized solution (100 cc.), containing the phenylalanine was determined with a polarimeter. [OC]DO =
-27.95 (C=l in water), optical purity equals 88.7%.
Example 3 Preparation of N-benzamidoacetonitrile Sodium carbonate (0.108 mole) was added to a solution containing 20 g. of aminoacetonitrile hydrochloride (0.216 mole) in 150 cc. of water. The solution was cooled to 5C. and 18.1 g.
(0.216 mole) of sodium bicarbonate was added. 30.4 g. of benzoyl chloride (0.216 mole) was added dropwise over about 1 1/2 hours to the cold aqueous solution and a solid formed. The resulting mass was allowed to warm to 20C.; the solid was collected and washed thoroughly with water. The dry weight of the recovered material, which was crude N-benzamidoacetonitrile, was 33 g.
(96% yield) m.p. 137-139C. This material was recrystallized from 100 cc. of methanol and 29 g. was recovered.
Example 4 Preparation of (Z)-2-benzamido-3-phenyl-2-propenenitrile Hydrogen chloride gas was bubbled into a solution con-taining 4 g. of benzaldehyde (0.037 mole) and 6 g. of N-benzamido-acetonitrile (0.037 mole) in 100 cc. of diethyl ether maintained at 0-5C. Upon holding for about 1 1/2 hours a solid precipitates;
10.4 g. of this solid was collected by filtration.
The 10.4 g. of the solid collected above was added to a solution of 4 g. of sodium carbonate in 100 cc. of cold (0-5C.) water. The mixture was stirred for 1 hour at 5C., then 10 cc.
of acetone was added and the resulting mass allowed ~o warm to 20C. The product, which was crude (Z)-2-benzamido-3-phenyl-2-propenenitrile (NMR), was eollected and washed with water. The dry weight of collected material was 8.5 g. (92% yield). The 8.5 g. of this material was crystalllzed from 85 cc. of ethanol.
Recovery was 6.8 g., m.p. 164-165.
Example 5 Preparation of 2-benzamido-3-phenylpropanenitrile (A) A solution of 0.9956 g. of (Z)-2-benzamido-3-phenyl-2-propenenitrile, .oo46 g. of cyclooctadiene-1,5-[1,2-bis (o-anisylphenylphosphino) ethane] rhodium tetrafluoroborate and 0.5 cc. of acetic acid in 30 cc. of methanol was hydrogenated in a Hoke bomb at 27 atm. and 50C. Hydrogenation was complete in
3 hours. The solution was diluted to 200 cc. with methanol, ob-served rotation = -0.359, [~C]20 = -72.1. The pure enantiomorph of 2-benzamido-3-phenylpropanenitrile in a solution of comparable composition has a [~X~]20 = -84.3. Therefore, the optical purity was 85.5%.
(B) A solution of 0.9924 g. of (Z)-2-benzamido-3-phenyl-2-propenenitrile, 0.0153 g. of cyclooctadiene-1,5-[1,2-bis(o-anisylphenylphosphino) ethane] rhodium tetrafluoroborate and 2 drops of acetic acid in 30 cc. of methanol was subjected to 3 atm. of hydrogen pressure at 50C. After about 24 hours, the solution was diluted to 200 cc. with methanol. The observed rotation was -0.372, ~]20 = _7~o. Therefore, the optical purity was 89%.
While the invention has been described herein with re-gard to certain specific embodiments, it is not so limited. It is to be understood that variations and modifications thereof may be made by those skilled in the art without departing from the spirit and scope of the invention.
(B) A solution of 0.9924 g. of (Z)-2-benzamido-3-phenyl-2-propenenitrile, 0.0153 g. of cyclooctadiene-1,5-[1,2-bis(o-anisylphenylphosphino) ethane] rhodium tetrafluoroborate and 2 drops of acetic acid in 30 cc. of methanol was subjected to 3 atm. of hydrogen pressure at 50C. After about 24 hours, the solution was diluted to 200 cc. with methanol. The observed rotation was -0.372, ~]20 = _7~o. Therefore, the optical purity was 89%.
While the invention has been described herein with re-gard to certain specific embodiments, it is not so limited. It is to be understood that variations and modifications thereof may be made by those skilled in the art without departing from the spirit and scope of the invention.
Claims (7)
1. An asymmetric hydrogenation process comprising hy-drogenating the Z geometric isomer of a compound of the formula wherein R and R1 each independently represent substituents as desired in the hydrogenation product or its derivatives, R2 represents -CN, or wherein R4 and R5 each indepen-dently represent hydrogen, alkyl having from 1 to 5 carbon atoms or aryl, R6 represents hydrogen, alkyl having from 1 to 5 carbon atoms, aryl or an alkali metal, and R3 represents or wherein R7 and R8 each independently represent alkyl having from 1 to 5 carbon atoms or aryl; provided that, when R3 is , R2 cannot be or , in the presence of a catalytic amount of a homogeneous, coordination complex of rhodium, iridium or ruthenium in combination with an optically active bis phosphine ligand represented by the formula wherein A and B each independently represent substituted and un-substituted alkyl of from 1 to 12 carbon atoms, substituted and unsubstituted cycloalkyl having from 4 to 7 carbon atoms, sub-stituted and unsubstituted aryl; provided that such substituents provide no significant interference with the steric requirements around the phosphorus atom and A and B are different.
2. A hydrogenation process according to Claim 1 wherein the bis phosphine ligand is represented by the formula wherein X represents substituted and unsubstituted phenyl, Y represents substituted and unsubstituted 2-alkoxyphenyl wherein the alkoxy has from 1 to 6 carbon atoms; pro-vided that such substitutents provide no significant interference with the steric requirements around the phosphorus atom and X and Y are different.
3. A hydrogenation process according to Claim 1 wherein the bis phosphine ligand is represented by the formula M - ? - CH2CH2 - ? - M
wherein M represents , N represents , R' and R" each independently represent hydrogen, halogen, alkyl having from 1 to 6 carbon atoms and alkoxy having from 1 to 6 carbon atoms, and R''' represents normal alkyl having from 1 to 6 carbon atoms;
provided that M and N are different.
wherein M represents , N represents , R' and R" each independently represent hydrogen, halogen, alkyl having from 1 to 6 carbon atoms and alkoxy having from 1 to 6 carbon atoms, and R''' represents normal alkyl having from 1 to 6 carbon atoms;
provided that M and N are different.
4. A hydrogenation process according to Claim 1 wherein the bis phosphine ligand is 1,2-bis(o-anisylphenylphosphino) ethane.
5. A process according to Claim 1 wherein the metal utilized in the catalyst complex is rhodium.
6. A hydrogenation process according to Claim 1 wherein the compound being hydrogenated is (Z)-ethyl-2-(N-ethoxycarbonyl-amino)-3-phenyl-2-propenoate.
7. A hydrogenation process according to Claim 2 wherein the compound being hydrogenated is (Z)-2-benzamido-3-phenyl-2-propenenitrile.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60730475A | 1975-08-25 | 1975-08-25 | |
| US607,304 | 1975-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1094094A true CA1094094A (en) | 1981-01-20 |
Family
ID=24431694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA259,753A Expired CA1094094A (en) | 1975-08-25 | 1976-08-24 | Asymmetric catalysis |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5227717A (en) |
| AU (1) | AU501233B2 (en) |
| BE (1) | BE845455A (en) |
| BR (1) | BR7605567A (en) |
| CA (1) | CA1094094A (en) |
| CH (1) | CH625204A5 (en) |
| DE (1) | DE2638071A1 (en) |
| FR (1) | FR2322131A1 (en) |
| GB (1) | GB1501599A (en) |
| MX (1) | MX3526E (en) |
| NL (1) | NL7609342A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879398A (en) * | 1987-12-31 | 1989-11-07 | Monsanto Company | Process for producing 2,6-disubstituted tyrosine |
| US4939288A (en) * | 1989-01-23 | 1990-07-03 | Monsanto Company | Method of preparing (R)-succinic acid derivatives |
| GB9823716D0 (en) | 1998-10-29 | 1998-12-23 | Isis Innovation | Diphosphines |
-
1976
- 1976-08-23 NL NL7609342A patent/NL7609342A/en not_active Application Discontinuation
- 1976-08-24 FR FR7625641A patent/FR2322131A1/en active Granted
- 1976-08-24 MX MX10040276U patent/MX3526E/en unknown
- 1976-08-24 JP JP10027976A patent/JPS5227717A/en active Pending
- 1976-08-24 DE DE19762638071 patent/DE2638071A1/en not_active Ceased
- 1976-08-24 AU AU17095/76A patent/AU501233B2/en not_active Expired
- 1976-08-24 BE BE170022A patent/BE845455A/en not_active IP Right Cessation
- 1976-08-24 CA CA259,753A patent/CA1094094A/en not_active Expired
- 1976-08-24 CH CH1074176A patent/CH625204A5/en not_active IP Right Cessation
- 1976-08-24 GB GB3512676A patent/GB1501599A/en not_active Expired
- 1976-08-24 BR BR7605567A patent/BR7605567A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5227717A (en) | 1977-03-02 |
| AU1709576A (en) | 1978-03-02 |
| BE845455A (en) | 1977-02-24 |
| AU501233B2 (en) | 1979-06-14 |
| FR2322131A1 (en) | 1977-03-25 |
| GB1501599A (en) | 1978-02-15 |
| FR2322131B1 (en) | 1982-07-09 |
| DE2638071A1 (en) | 1977-03-10 |
| MX3526E (en) | 1981-01-26 |
| BR7605567A (en) | 1977-08-09 |
| NL7609342A (en) | 1977-03-01 |
| CH625204A5 (en) | 1981-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4220590A (en) | Asymmetric catalysis | |
| US4556740A (en) | Phosphorus compounds | |
| Riley et al. | 1, 2-Bis (diphenylphosphino)-1-cyclohexylethane. A new chiral phosphine ligand for catalytic chiral hydrogenations | |
| Burk et al. | New chiral phospholanes; synthesis, characterization, and use in asymmetric hydrogenation reactions | |
| Lightfoot et al. | Enantioselective hydrogenation of olefins with iridium–phosphanodihydrooxazole catalysts | |
| ES2654530T3 (en) | Phospholanes and p-chiral phosphocyclic compounds and their use in asymmetric catalytic reactions | |
| EP0631571B1 (en) | Preparation of optically active hydrazines and amines | |
| US5693820A (en) | Ruthenium complexes with a chiral, bidentate phosphine/oxazoline ligand for enantioselective transfer hydrogenation of prochiral ketones | |
| US4142992A (en) | Asymmetric catalysis | |
| EP1469004B1 (en) | Method for preparing aminophosphines and aminophosphine oxides, intermediates therefor | |
| CA1094094A (en) | Asymmetric catalysis | |
| US4400551A (en) | Process for the production of acetaldehyde and ethanol | |
| CA1142947A (en) | Optically active 1,2-bis-(diphenyl-phosphino) compounds and metal complexes containing them as chiral ligands as well as their use | |
| US4515731A (en) | Asymmetric catalysis | |
| CA1162542A (en) | Catalytic asymmetric hydrogenation | |
| Roucoux et al. | Rhodium (I) bis (aminophosphane) complexes as catalysts for asymmetric hydrogenation of activated ketones | |
| IL44084A (en) | Homogeneous catalytic reduction of 6-methylenetetracyclines | |
| JP4028625B2 (en) | Phosphine compounds and rhodium complexes using them as ligands | |
| Catellani et al. | A new catalytic synthesis of non-conjugated alkenynes | |
| US5118825A (en) | Ruthenium phosphine complex | |
| US4194051A (en) | Asymmetric catalysis | |
| CN112824423B (en) | Chiral ferrocenylphosphine-indolylaminophosphine ligand and preparation method and application thereof | |
| CA1094095A (en) | Asymmetric catalysis | |
| US4187241A (en) | Metal phosphine complex | |
| JPS5826841A (en) | Manufacture of optical arylpropionic acid ester |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |